semaglutide and epilepsy A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025 GLP-1 Diabetes Medications Linked to

However, some individuals may need to take additional precautions

What Theyre FDA-Approved For Currently, GLP-1 medications are approved for: Type 2 diabetes Obesity and weight management Reducing cardiovascular risk in people with heart or kidney disease MASH (metabolic-associated steatohepatitis) , formerly called NASH, a type of fatty liver disease Microdosing: What It Means Microdosing usually refers to staying at a very low dosesay, 0.25 mg of semaglutidelong-term, rather than gradually increasing to the therapeutic dose

Taking short walks or parking farther away from your destination can help increase your daily step count

With the right strategies and support from the Hopkins MD team, you can minimize discomfort and focus on the benefits these medications offer

Ozempic may also be prescribed off-label for help with weight management